MINISTRY OF
HEALTH |
SOCIALIST
REPUBLIC OF VIETNAM |
No. 19/2018/TT-BYT |
Hanoi, August 30, 2018 |
CIRCULAR
INTRODUCING LIST OF ESSENTIAL MEDICINES
Pursuant to the Law on Pharmacy No. 105/2016/QH13 dated April 6, 2016;
Pursuant to the Government's Decree No. 75/2017/ND-CP dated June 20, 2017, defining the functions, tasks, powers and organizational structure of the Ministry of Health;
Upon the request of the Director of the Traditional Medicine Administration of Vietnam and the Director of the Drug Administration of Vietnam;
The Minister of Health hereby promulgates the Circular that introduces the list of essential medicines.
Article 1. Scope
This Circular prescribes the principles for developing and criteria for selecting essential medicines, including chemical medicines, vaccines, biologicals, traditional medicines and herbal medicines; the list of essential medicines; use of the list of essential medicines and task performance responsibilities.
Article 2. Principles for developing and criteria for selecting medicines appearing on the list of essential medicines
1. Principles for developing the list of essential medicines:
a) The list must be developed on the basis of the criteria for selection of medicines prescribed in Clause 2 of this Article, instructions for diagnosis and treatment as well as technical and professional procedures promulgated by the Minister of Health; must inherit the list of essential medicines of Vietnam (sixth edition) and consult the list of essential medicines of the World Health Organization;
b) The list must comply with the policies and laws on medicines, conform with actual demands and capabilities of supplying medicines in Vietnam;
c) Naming of medicines on the list of essential medicines shall be subject to the following regulations:
- Use of the given names of medicines shall not be accepted;
- Chemical medicines and biologicals shall be classified by the common international names of active ingredients or active compounds used in the composition of medicines;
- Vaccines shall be classified by their types or ingredient names (for instance, Hepatitis B vaccine);
- Traditional medicinal products shall be classified by herbal ingredient names including common Vietnamese names and scientific names. Vietnamese names of herbal ingredients may vary but their scientific names must be the same;
- Herbal medicines and traditional medicines (except traditional medicinal ingredients) shall be classified by the Vietnamese name of each herbal ingredient or medicinal ingredient used in the same medicinal formula. If Vietnamese names of herbal ingredients or medicinal ingredients vary, the scientific names of herbal ingredients shall be preferred.
2. The criteria for selecting medicines eligible to be on the list of essential medicines shall include:
Medicines will be considered to be on the list of essential medicines if the following criteria are satisfied:
a) General requirements:
- Ensure safety and efficaciousness for users;
- Meet the healthcare needs of the population.
b) Specific requirements:
- With respect to chemical medicines and biologicals, single-ingredient medicines shall be preferred. In case of multi-ingredient medicines, it shall be proved that the combination of multiple ingredients with different effects and safety levels brings about more benefits;
- With respect to vaccines, those vaccines used in the expanded program on immunization, those vaccines that are likely to be domestically formulated and approved for circulation in Vietnam, those vaccines used in major epidemics, and those vaccines used for preventing diseases posing dangers to the user's life, shall be preferred;
- With respect to traditional medicines (except traditional medicinal ingredients), those medicines formulated in Vietnam, those medicinal products formulated in State-, Ministry-, provincial-level or equivalent projects which have been tested before acceptance and have obtained certificates of registration for marketing authorization, and those medicinal products derived from the list of traditional medicines which has been approved by the Ministry of Health, shall be preferred;
- With respect to traditional medicinal ingredients, those medicinal products formulated from herbal ingredients present in the Pharmacopoeia of Vietnam; those medicinal products formulated from indigenous herbal ingredients, and those formulated from herbal ingredients on the list of herbal products that are cultivated or harvested domestically to meet therapeutic demands and supply capabilities, shall be preferred;
- With respect to herbal medicines, those herbal medicines composed of herbal ingredients or herbal compounds that are named in the list of traditional medicinal ingredients as part of the list of essential traditional medicinal products.
Article 3. List of essential medicines
The list of essential medicines shall be appended to this Circular, including:
1. List of essential chemical medicines, vaccines and biologicals (Appendix I)
2. List of essential traditional medicines, traditional medicinal ingredients and herbal medicines:
a) Traditional medicines derived from the list of traditional remedies which are recognized by the Ministry of Health and are exempted from clinical tests;
b) Herbal medicines, including those obtaining certificates of marketing authorization in Vietnam and containing herbal ingredients appearing on the list of essential traditional medicinal ingredients hereto appended.
c) Medicines listed according to the list of traditional medicines with certificates of marketing authorization in Vietnam hereto appended (Appendix II);
d) List of traditional medicinal ingredients (Appendix II).
Article 4. Use of the list of essential medicines
The list of essential medicines shall be used for the following purposes:
1. The list assists in developing the unified system of regulatory policies on investment, administration of prices, funds, taxes and fees relating to manufacturing, trading, storage, testing, export and import of medicines and pharmaceutical materials in order to ensure the number of medicines on the list of essential medicines is adequate for the tasks of protecting, taking care of and improving the population's health.
2. The list is used as training, teaching materials and manuals for use of medicines to students and learners of educational institutions with healthcare training disciplines.
3. Based on the list, another list of medicines for which payments are covered by the health insurance fund shall come into existence.
4. The list is served as a basis for the Drug and Medical Treatment Council to prepare the list of medicines used by healthcare establishments to meet treatment demands for submission to the heads of healthcare establishments to seek approval decisions.
5. The list is served as a basis for establishing the list of medicines subject to the bidding process, the list of medicines subject to the centralized procurement process and the list of medicines subject to the price negotiation method.
6. The list defines which medicines are sold at retailing establishments that are communal-level health stations’ drug cabinets, including:
a) Medicines bearing the symbol (*) in the list of essential chemical medicines and biologicals;
b) All of essential herbal medicines, traditional medicines and traditional medicinal ingredients hereto appended.
Article 5. Entry into force
1. This Circular shall enter into force from October 15, 2018.
2. The Circular No. 40/2013/TT-BYT dated November 18, 2013 of the Minister of Health on promulgation of the list of essential oriental medicines and herbal medicines, and the Circular No. 45/2013/TT-BYT dated December 26, 2013 of the Minister of Health on promulgation of the list of essential modern medicines (sixth edition), shall be repealed from the entry into force of this Circular.
Article 6. Transitional provisions
If healthcare establishments uses the list of essential medicines prescribed in the Circular No. 40/2013/TT-BYT dated November 18, 2013 of the Minister of Health on promulgation of the list of essential oriental medicines and herbal medicines, and the Circular No. 45/2013/TT-BYT dated December 26, 2013 of the Minister of Health on promulgation of the list of essential modern medicines (sixth edition), as a basis for developing the lists specified in Article 4 hereof before the Circular’s entry into force, they shall be entitled to continue to comply with provisions laid down in the abovementioned legislative documents, but shall be required to carry out any necessary review and update in compliance with this Circular no later than 12 months from the entry into force of this Circular.
Article 7. Implementary responsibilities
Drug Administration of Vietnam, Traditional Medicine Administration of Vietnam, the Medical Examination and Treatment Administration, the Planning – Finance Department, affiliates of the Ministry of Health, sectoral-level healthcare units, Departments of Health of centrally-affiliated cities and provinces, Vietnam Pharmaceutical Corporation, healthcare service providers, pharmaceutical production and business facilities, organizations and individuals concerned, shall be responsible for implementing this Circular.
In the course of implementation of this Circular, if there is any difficulty that arises, entities, organizations and individuals should promptly inform the Ministry of Health (Drug Administration of Vietnam, and Traditional Medicine Administration of Vietnam) for its possible decisions./.
|
PP. MINITER |
APPENDIX I
NOMENCLATURE
OF essential CHEMICAL
MEDICATIONS, vaccines AND
BIOLOGICALS
(enclosed with Circular No. 19/2018/TT-BYT dated August 30, 2018 of the
Minister of Health of Vietnam)
No. |
Name |
Administration route |
Dosage form |
Concentration, content |
(1) |
(2) |
(3) |
(4) |
(5) |
I. Local anesthetics, general anesthetics |
||||
1. General anesthetics and oxygen |
||||
1 |
Fentanyl (citrate) |
Injection |
Solution |
0,05mg/ml |
2 |
Halothane |
Respiratory route |
Solution |
187g/100ml |
3 |
Ketamine (hydrochloride) |
Injection |
Solution |
50mg/ml |
4 |
Pharmaceutical oxygen |
Respiratory route |
Liquefied gas |
|
5 |
Thiopental (sodium) |
Injection |
Powder for injection |
500mg, 1g |
2. Local anesthetics |
||||
6 |
Bupivacaine hydrochloride |
Injection |
Solution |
0,25%, 0,5% |
7 |
Lidocaine hydrochloride |
Injection |
Solution |
1%, 2% |
8 |
Procaine hydrochloride |
Injection |
Solution |
1%, 3%, 5% |
9 |
Lidocaine hydrochloride + Adrenaline |
Injection |
Solution |
1%, 2% + 1:200 000 |
10 |
Ephedrine hydrochloride |
Injection |
Solution |
30mg/ml |
3. Pre-anesthetic agents and short-acting sedatives |
||||
11 |
Atropine sulfate |
Injection |
Solution |
0,25 mg/ml; 1 mg/ml |
12 |
Diazepam |
Injection |
Solution |
5mg/ml |
13 |
Morphine hydrochloride or Sulfate |
Injection |
Solution |
10mg/ml |
II. MEDICATIONS USED in pain management and palliative care |
||||
1. Non‐opioid analgesics, antipyretic agents, non-steroidal anti-inflammatory drugs (nsaid) |
||||
14 |
Acetylsalicylic Acid (*) |
Oral administration |
Tablets/capsules |
100mg - 500mg |
Powder for solution |
100mg |
|||
15 |
Diclofenac |
Oral administration |
Tablets/capsules |
25mg, 50mg, 75mg, 100mg |
16 |
Ibuprofen (*) |
Oral administration |
Tablets/capsules |
200mg, 400mg |
Solution |
40mg/ml |
|||
17 |
Meloxicam |
Oral administration |
Tablets/capsules |
7,5mg, 15mg |
Injection |
Solution |
10mg/ml |
||
18 |
Paracetamol (*) |
Oral administration |
Tablets/capsules |
80mg, 100mg, 250mg, 500mg |
Powder for solution |
80mg, 100mg, 250mg, 500mg |
|||
Rectal administration |
Suppositories |
80mg, 150mg, 300mg |
||
19 |
Piroxicam |
Injection |
Solution |
20mg/ml |
Oral administration |
Tablets/capsules |
10mg, 20mg |
||
2. Opioid analgesics |
||||
20 |
Morphine hydrochloride or Sulfate |
Injection |
Solution |
10mg/ml |
21 |
Morphine Sulfate |
Oral administration |
Tablets/capsules |
10mg, 30mg |
Morphine hydrochloride or Sulfate |
Delayed-release tablets |
10mg - 200mg |
||
Solution |
2mg/ml |
|||
22 |
Pethidine hydrochloride |
Injection |
Solution |
25mg/ml, 50mg/ml |
3. Palliative care medicines |
||||
23 |
Amitriptyline |
Oral administration |
Tablets/capsules |
10mg, 25mg |
24 |
Cyclizine |
Injection |
Solution |
50mg/ml |
Oral administration |
Tablets/capsules |
50mg |
||
25 |
Dexamethason |
Oral administration |
Tablets/capsules |
2mg |
Dexamethason phosphate (sodium) |
Injection |
Solution |
4mg/ml |
|
26 |
Diazepam |
Injection |
Solution |
5mg/ml |
Oral administration |
Solution |
0,4mg/ml |
||
Tablets |
5mg, 10mg |
|||
Rectal administration |
Syringe |
2,5mg, 5mg, 10mg |
||
27 |
Docusate sodium (*) |
Oral administration |
Tablets/capsules |
100mg |
Solution |
10mg/ml |
|||
28 |
Fluoxetin (hydrochloride) |
Oral administration |
Tablets/capsules |
20mg |
29 |
Hyoscin butylbromide |
Injection |
Solution |
20mg/ml |
30 |
Hyoscin hydrobromide |
Injection |
Solution |
400mg/ml, 600mg/ml |
Topical administration |
Transdermal patch |
1mg/72 hours |
||
31 |
Lactulose (*) |
Oral administration |
Solution, Syrup |
0,62 - 0,74g/ml |
32 |
Midazolam |
Injection |
Solution |
1mg/ml, 5mg/ml |
33 |
Ondansetron (hydrochloride) |
Injection |
Solution |
2mg/ml |
Oral administration |
Solution |
0,8mg/ml |
||
Tablets |
4mg, 8mg |
|||
III. Medications used to treat allergies and drug hypersensitivity reactions (DHR) |
||||
34 |
Alimemazine (*) |
Oral administration |
Tablets/capsules |
5mg |
Syrup |
5mg/ml |
|||
35 |
Clorpheniramine maleate |
Oral administration (*) |
Tablets/capsules |
4mg |
Syrup |
0,4mg/ml |
|||
Injection |
Solution |
10mg/ml |
||
36 |
Dexamethason |
Oral administration |
Tablets/capsules |
0,5mg, 1mg |
Dexamethason phosphate (sodium) |
Injection |
Solution |
4mg/ml |
|
37 |
Adrenaline (tartrate or hydrochloride) |
Injection |
Solution |
1 mg/ml |
38 |
Hydrocortison acetate |
Injection |
Suspension |
25mg/ml, 50mg/ml |
Hydrocortison (sodium succinate) |
Powder for injection |
100mg |
||
39 |
Methylprednisolon (sodium succinate) |
Injection |
Powder for Injection |
40mg |
Methylprednisolon acetate |
Injection |
Suspension |
40mg/ml |
|
40 |
Prednisolon |
Oral administration |
Tablets/capsules |
5mg |
Syrup |
5mg/ml |
|||
41 |
Loratadine (*) |
Oral administration |
Tablets/capsules |
10mg |
42 |
Promethazine hydrochloride (*) |
Oral administration |
Tablets |
10mg, 50mg |
Syrup |
1,25mg/ml, 5mg/ml |
|||
IV. ANTIDOTES |
||||
1. Specific antidotes |
||||
43 |
Atropin Sulfate |
Injection |
Solution |
0,25mg/ml, 0,5mg/ml |
44 |
Deferoxamine mesylate |
Infusion |
Lyophilized powder |
500mg, 1g |
45 |
Dimercaprol |
Injection |
Oil solution |
25mg/ml |
46 |
Hydroxocobalamin (acetate or chloride or Sulfate) |
Injection |
Solution |
1mg/ml |
47 |
Methionine |
Oral administration |
Tablets/capsules |
250mg |
48 |
Naloxone (hydrochloride) |
Injection |
Solution |
0,4mg/ml |
49 |
Sodium Calcium edetate |
Injection |
Solution |
200mg/ml |
50 |
Sodium thiosulfate |
Injection |
Solution |
200mg/ml, 250mg/ml |
51 |
Penicilamine |
Oral administration |
Tablets/capsules |
250mg |
Injection |
Powder for Injection |
1g |
||
52 |
Pralidoxime chloride |
Injection |
Powder for Injection |
1g |
53 |
Methylene blue |
Injection |
Solution |
1% |
54 |
Acetylcystein |
Injection |
Solution |
200mg/ml |
Oral administration |
Solution |
10%, 20% |
||
55 |
Calcium gluconate |
Injection |
Solution |
100mg/ml |
56 |
Potassium Ferrocyanide |
Oral administration |
Powder for solution, tablets/capsules |
|
57 |
Sodium nitrite |
Injection |
Solution |
30mg/ml |
2. Nonspecific antidotes |
||||
58 |
Activated carbon (*) |
Oral administration |
Powder for suspension, tablets/capsules |
|
V. Anticonvulsants/antiepileptic drugs |
||||
59 |
Valproate (Sodium) |
Oral administration |
Tablets/capsules |
100mg, 200mg, 500mg |
Syrup |
40mg/ml |
|||
60 |
Carbamazepine |
Oral administration |
Tablets/capsules |
100mg, 200mg |
Suspension |
20mg/ml |
|||
61 |
Diazepam |
Oral administration |
Tablets/capsules |
5mg |
Injection |
Solution |
5mg/ml |
||
62 |
Magnesium sulfate |
Injection |
Solution |
10%, 20% |
63 |
Phenobarbital |
Oral administration |
Tablets/capsules |
10mg, 100mg |
Solution |
3mg/ml |
|||
Phenobarbital (Sodium) |
Injection |
Solution |
100mg/ml, 200mg/ml |
|
64 |
Phenytoin (sodium) |
Oral administration |
Tablets/capsules |
25mg, 50mg, 100mg |
Suspension |
5mg/ml |
|||
Injection |
Solution |
50mg/ml |
||
65 |
Ethosuximide |
Oral administration |
Tablets/capsules |
250mg |
Syrup |
50mg/ml |
|||
VI. Medications used to treat parasitic infections or bacterial infections |
||||
1. Anthelmintics |
||||
a. Medications for treatment of intestinal helminthic infections |
||||
66 |
Albendazol(*) |
Oral administration |
Tablets/capsules |
200mg, 400mg |
67 |
Mebendazol (*) |
Oral administration |
Tablets/capsules |
100mg, 500mg |
68 |
Niclosamid |
Oral administration |
Tablets/capsules |
500mg |
69 |
Praziquantel |
Oral administration |
Tablets/capsules |
150mg, 600mg |
70 |
Pyrantel (embonate) (*) |
Oral administration |
Tablets/capsules |
250mg |
Suspension |
50mg/ml |
|||
b. Medications for treatment of filariasis |
||||
71 |
Diethylcarbamazine dihydrogen citratee |
Oral administration |
Tablets/capsules |
50mg, 100mg |
72 |
Ivermectin |
Oral administration |
Tablets/capsules |
3mg, 6mg |
c. Medications for treatment of trematode infections |
||||
73 |
Metrifonate |
Oral administration |
Tablets/capsules |
100mg |
74 |
Praziquantel |
Oral administration |
Tablets/capsules |
600mg |
75 |
Triclabendazole |
Oral administration |
Tablets/capsules |
250mg |
76 |
Oxamniquine |
Oral administration |
Tablets/capsules |
250mg |
Solution |
50mg/ml |
|||
2. Anti-infective drugs |
||||
a. Beta-lactames |
||||
77 |
Amoxicillin |
Oral administration |
Tablets/capsules |
250mg, 500mg |
Powder for suspension |
125mg, 250mg |
|||
Injection |
Powder for Injection |
500mg, 1g |
||
78 |
Amoxicillin and Clavulanic acid |
Oral administration |
Tablets/capsules |
500mg + 125mg, 250mg + 62,5mg, 125mg +31,25mg |
Powder for suspension |
500mg + 125mg/5ml, 250mg + 62,5mg/5ml, 125mg + 31,25mg/5ml (after combination) |
|||
Injection |
Powder for Injection |
500mg + 100mg, 1g + 200mg |
||
79 |
Ampicillin (Sodium) |
Injection |
Powder for Injection |
500mg, 1g |
80 |
Benzylpenicillin (benzathine) |
Injection |
Powder for Injection |
600.000 IU, 1.200.000 IU, 2.400.000 IU |
81 |
Benzylpenicillin (sodium or potassium) |
Injection |
Powder for Injection |
500.000 lU, 1.000.000 IU |
82 |
Benzylpenicillin (procaine) |
Injection |
Powder for Injection |
400.000 IU, 1.000.000 IU |
83 |
Cefalexin |
Oral administration |
Powder for suspension |
125mg/5ml, 250mg/5ml (after combination) |
Tablets/capsules |
125mg, 250mg, 500mg |
|||
84 |
Cefazolin (Sodium) |
Injection |
Powder for Injection |
250mg, 500mg, 1g |
85 |
Cefixime |
Oral administration |
Tablets/capsules |
100mg, 200mg |
86 |
Cefolaxime (Sodium) |
Injection |
Powder for Injection |
250mg, 500mg, 1 g |
87 |
Ceftriaxone (Sodium) |
Injection |
Powder for Injection |
250mg, 1g |
88 |
Cefuroxime (axetil) |
Oral administration |
Tablets/capsules |
250mg, 500mg |
Cefuroxime (Sodium) |
Injection |
Powder for Injection |
750mg, 1,5g |
|
89 |
Cloxacilline (Sodium) |
Oral administration |
Tablets/capsules |
250mg, 500mg |
Injection |
Powder for Injection |
500mg |
||
90 |
Phenoxymethyl penicillin |
Oral administration |
Tablets/capsules |
200.000 IU, 400.000 IU, 1.000.000 IU |
91 |
Imipenem + cilastatin |
Injection |
Powder for Injection |
250mg + 250mg, 500mg + 500mg, 750mg + 750mg |
b.Other antibacterial drugs |
||||
♦ Aminoglycosides |
||||
92 |
Amikacin |
Injection |
Powder for Injection |
250mg, 500mg |
Solution |
||||
93 |
Gentamicin (sulfate) |
Injection |
Solution |
10mg/ml, 20mg/ml, 40mg/ml |
94 |
Spectinomycin |
Injection |
Powder for Injection |
2g |
95 |
Vancomycin |
Injection |
Powder for Injection |
500mg |
♦ Chloramphenicols |
||||
96 |
Cloramphenicol |
Oral administration |
Tablets/capsules |
250mg |
Cloramphenicol (palmitate) |
Suspension |
30mg/ml |
||
Cloramphenicol (sodium succinate) |
Injection |
Powder for Injection |
1g |
|
♦ Nitroimidazoles |
||||
97 |
Metronidazole |
Oral administration |
Tablets/capsules |
250mg, 500mg |
Retal administration |
Suppositories |
500mg, 1g |
||
Infusion |
Solution |
5mg/ml |
||
Metronidazole (benzoate) |
Oral administration |
Suspension |
40mg/ml |
|
♦ Lincosamides |
||||
98 |
Clindamycin (hydrochloride) |
Oral administration |
Tablets/capsules |
150mg, 300mg |
Clindamycin (palmitate) |
Solution |
15mg/ml |
||
Clindamycin (phosphate) |
Injection |
Solution |
150mg/ml |
|
♦ Macrolides |
||||
99 |
Azithromycin |
Oral administration |
Tablets/capsules |
500mg |
Powder for suspension |
200mg/5ml (after combination) |
|||
100 |
Clarithromycin |
Oral administration |
Tablets/capsules |
250mg, 500mg |
101 |
Erythromycin |
Injection |
Powder for Injection |
500mg |
Erythromycin (stearate or ethylsuccinate) |
Oral administration |
Tablets/capsules |
250mg, 500mg |
|
Granules for suspension |
125mg/5ml (after combination) |
|||
♦ Quinolones |
||||
102 |
Ciprofloxacin (hydrochloride) |
Oral administration |
Tablets/capsules |
250mg, 500mg |
Ciprofloxacin (base or hydrochloride) |
Infusion |
Solution |
2mg/ml |
|
103 |
Levofloxacin |
Oral administration |
Film-coated tablets |
250mg, 500mg, 750mg |
♦ Sulfamides |
||||
104 |
Sulfamethoxazole + Trimethoprim |
Oral administration |
Tablets/capsules |
800mg + 160mg, 400mg +80 mg, 100mg + 20mg |
Suspension |
40mg + 8mg/ml |
|||
Infusion |
Solution |
80mg + 16mg/ml |
||
♦ Nitrofurans |
||||
105 |
Nitrofurantoin |
Oral administration |
Tablets/capsules |
100mg |
Suspension |
5mg/ml |
|||
♦ Tetracyclines |
||||
106 |
Doxycycline (hydrochloride) |
Oral administration |
Tablets/capsules |
50mg, 100mg |
Suspension |
5mg/ml, 10mg/ml |
|||
c. Medications for treatment of leprosy |
||||
107 |
Clofazimin |
Oral administration |
Tablets/capsules |
50mg, 100mg |
108 |
Dapson |
Oral administration |
Tablets/capsules |
25mg, 50mg, 100mg |
109 |
Rifampicin |
Oral administration |
Tablets/capsules |
150mg, 300mg |
Suspension |
1% |
|||
d. Medications for treatment of tuberculosis |
||||
110 |
Ethambutol hydrochloride |
Oral administration |
Tablets/capsules |
100mg, 400mg |
Solution or suspension |
25mg/ml |
|||
111 |
Isoniazid |
Oral administration |
Tablets/capsules |
50mg, 100mg, 150mg, 300mg |
Syrup |
50mg/5ml |
|||
112 |
Pyrazinamide |
Oral administration |
Tablets/capsules |
60mg, 150mg, 400mg |
113 |
Rifampicin + Isoniazid |
Oral administration |
Tablets/capsules |
300mg + 150mg, 150mg +100mg. 150mg + 75mg, 150 mg + 150mg, 60mg + 60mg |
114 |
Rifampicin |
Oral administration |
Tablets/capsules |
150mg, 300mg |
115 |
Streptomycin (sulfate) |
Injection |
Powder for Injection |
1g |
116 |
Ethambutol + Isoniazid |
Oral administration |
Tablets/capsules |
400mg + 150mg |
117 |
Ethambutol + Isoniazid + Pyrazinamide + Rifampicin |
Oral administration |
Tablets/capsules |
275mg+ 75mg+ 400mg + 150mg |
118 |
Ethambutol + Isoniazid + Rifampicin |
Oral administration |
Tablets/capsules |
275 mg + 75mg + 150mg |
119 |
Isoniazid + Pyrazinamide + Rifampicin |
Oral administration |
Tablets/capsules |
75mg + 400mg + 150mg, 150mg + 500mg + 150mg |
120 |
Rifabutin |
Oral administration |
Tablets/capsules |
150mg |
dd. Medications for prophylaxis of multidrug-resistant tuberculosis (MDR-TB) |
||||
121 |
Amikacin |
Injection |
Powder for Injection |
100mg. 500mg, 1g |
122 |
Capreomycin |
Injection |
Powder for Injection |
1g |
123 |
Cycloserin |
Oral administration |
Tablets/capsules |
250mg |
124 |
Ethionamide |
Oral administration |
Tablets/capsules |
125mg, 250mg |
125 |
Kanamycin |
Injection |
Powder for Injection |
1g |
126 |
Ofloxacin |
Oral administration |
Tablets/capsules |
200mg, 400mg |
127 |
Para-aminosalicylic acid (PAS) |
Oral administration |
Tablets/capsules |
500mg |
Cốm |
4g |
|||
3. Antifungal medications |
||||
128 |
Amphotericin B |
Injection |
Powder for Injection |
50mg |
129 |
Clotrimazole (*) |
Vagina |
Pessaries |
50mg, 100mg, 500mg |
Topical administration |
Vaginal cream |
1%, 10% |
||
130 |
Fluconazole |
Oral administration |
Tablets/capsules |
50mg, 150mg |
Powder for suspension |
10mg/ml (after combination) |
|||
Injection |
Solution |
2mg/ml |
||
131 |
Griseofulvin |
Oral administration |
Tablets/capsules |
125mg, 250mg, 500mg |
Suspension |
25mg/ml |
|||
132 |
Nystatin |
Oral administration |
Tablets/capsules |
250.000IU, 500.000IU |
Suspension |
100.000IU/ml |
|||
Vagina |
Pessaries |
100.000 IU |
||
133 |
Flucytosine |
Oral administration |
Tablets/capsules |
250mg |
Infusion |
Solution |
10mg/ml |
||
134 |
Potassium iodide |
Oral administration |
Solution |
1g/ml |
4. Antiprotozoal drugs |
||||
a. Antiamoebic drugs/ medications for treatment of amoebiasis |
||||
135 |
Diloxanid furoate |
Oral administration |
Tablets/capsules |
500mg |
136 |
Metronidazole |
Oral administration |
Tablets/capsules |
250mg, 500mg |
Infusion |
Solution |
5mg/ml |
||
b. Antimalarial drugs/ medications for prevention and treatment of malaria |
||||
♦ Drugs for prevention of malaria |
||||
137 |
Chloroquine phosphate or Chloroquine sulfate |
Oral administration |
Tablets/capsules |
150mg |
Syrup |
10mg/ml |
|||
138 |
Mefloquine |
Oral administration |
Tablets/capsules |
250mg |
139 |
Doxycycline (hydrochloride) |
Oral administration |
Tablets/capsules |
100mg |
140 |
Proguanil |
Oral administration |
Tablets/capsules |
100mg |
♦ Drugs for treatment of malaria |
||||
141 |
Amodiaquine |
Oral administration |
Tablets/capsules |
153mg, 200mg |
142 |
Artesunate |
Injection |
Powder for Injection |
60mg (with 0,6ml of 5% sodium carbonate solution for injection) |
143 |
Artesunate + Amodiaquine |
Oral administration |
Tablets/capsules |
25mg+ 67,5mg, 50mg + 135mg, 100mg + 270mg |
144 |
Artesunate + Mefloquine |
Oral administration |
Tablets/capsules |
25mg + 55 mg, 100mg + 220mg |
145 |
Chloroquine (phosphate or sulfate) |
Oral administration |
Tablets/capsules |
100mg, 150mg, 250mg |
Syrup |
10mg/ml |
|||
146 |
Primaquine |
Oral administration |
Tablets/capsules |
7,5mg, 15mg |
147 |
Quinine dihydrochloride |
Injection |
Solution |
150mg/ml, 300mg/ml |
148 |
Quinine sulfate or Quinine bisulfate |
Oral administration |
Tablets/capsules |
300mg |
149 |
Sulfadoxine + Pyrimethamine |
Oral administration |
Tablets/capsules |
500mg + 25mg |
150 |
Artemether |
Injection |
Oil solution |
80mg/ml |
151 |
Artemether + Lumefantrine |
Oral administration |
Tablets/capsules |
20mg + 120mg |
152 |
Doxycycline (hydrochloride) |
Oral administration |
Tablets/capsules |
100mg |
c. Drugs for treatment of infection due to Pneumocytis carinii and Toxoplasma |
||||
153 |
Pyrimethamine |
Oral administration |
Tablets/capsules |
25mg |
154 |
Sulfamethoxazole + Trimethoprim |
Oral administration |
Tablets/capsules |
100mg + 20mg, 400mg + 80mg |
Suspension |
40mg + 8mg/ml |
|||
Infusion |
Solution |
80mg + 16mg/ml |
||
155 |
Sulfadiazine |
Oral administration |
Tablets/capsules |
500mg |
156 |
Pentamidine |
Oral administration |
Tablets/capsules |
200mg, 300mg |
5. Antiviral medications |
||||
a. Antiviral drugs for treatment of herpes infections |
||||
157 |
Aciclovir |
Oral administration |
Tablets/capsules |
200mg, 800mg |
Suspension |
40mg/ml |
|||
Topical administration (*) |
Cream |
5% |
||
Injection |
Powder for Injection |
250mg |
||
158 |
Ribavirin |
Oral administration |
Tablets/capsules |
200, 400, 600 mg |
Injection |
Solution |
800mg, 1g/10ml phosphate-buffered solution |
||
b. Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) |
||||
159 |
Lamivudine |
Oral administration |
Tablets/capsules |
150 mg |
Solution |
10mg/ml |
|||
160 |
Nevirapine |
Oral administration |
Tablets/capsules |
200mg |
Suspension |
10mg/ml |
|||
161 |
Zidovudine |
Oral administration |
Tablets/capsules |
100mg, 250mg, 300mg |
Syrup |
10mg/ml |
|||
Infusion |
Solution |
10mg/ml |
||
162 |
Abacavir (sulfate) |
Oral administration |
Tablets/capsules |
300 mg |
Solution |
20mg/ml |
|||
163 |
Tenofovir disoproxil fumarate |
Oral administration |
Tablets/capsules |
150mg, 200mg, 250mg, 300mg |
c. Protease inhibitors |
||||
164 |
Atazanavir (Sulfate) |
Oral administration |
Tablets/capsules |
100mg, 150mg. 300mg |
165 |
Efavirenz |
Oral administration |
Tablets/capsules |
50mg, 150mg, 200mg, 300mg |
Syrup |
30mg/ml |
|||
166 |
Lopinavir + Ritonavir |
Oral administration |
Tablets/capsules |
100mg + 25mg, 200mg + 50mg |
Solution |
80mg + 20mg/ml |
|||
167 |
Ritonavir |
Oral administration |
Tablets/capsules |
100mg |
Solution |
80mg/ml |
|||
d. Fixed-dose combination drugs |
||||
168 |
Lamivudine + Tenofovir |
Oral administration |
Tablets/capsules |
300mg + 300mg |
169 |
Lamivudine + Tenofovir + Efavirenz |
Oral administration |
Tablets/capsules |
300mg + 300mg + 600mg |
170 |
Lamivudine + Zidovudine + Nevirapine |
Oral administration |
Tablets/capsules |
150mg + 300mg + 200mg, 60mg + 120mg + 100mg, 30mg + 60mg + 50mg |
171 |
Lamivudine + Zidovudine |
Oral administration |
Tablets/capsules |
150 mg + 300mg, 60mg + 120mg, 30mg + 60mg |
dd. Other drugs |
||||
172 |
Oseltamivir |
Oral administration |
Tablets/capsules |
30mg, 45mg, 75mg |
Powder for suspension |
12mg/ml |
|||
VII. ANTIMIGRAINE DRUGS |
||||
1. Medications for treatment of acute pain |
||||
173 |
Acetylsalicylic acid (*) |
Oral administration |
Tablets/capsules |
300mg - 500mg |
174 |
Ibuprofen (*) |
Oral administration |
Tablets/capsules |
200mg, 400mg |
175 |
Paracetamol (*) |
Oral administration |
Tablets/capsules |
300 mg - 500mg |
Solution |
125mg/ml |
|||
2. Medications for disease prevention |
||||
176 |
Proparacaine hydrochloridee |
Oral administration |
Tablets/capsules |
20mg, 40mg |
viii. ANTI-CANCER DRUGS AND Immune system modulators |
||||
1. Immunosuppressive drugs |
||||
177 |
Azathioprine |
Oral administration |
Tablets/capsules 50mg |
50mg |
Injection |
Powder for Injection |
100mg |
||
178 |
Ciclosporin |
Oral administration |
Tablets/capsules |
25mg |
Injection |
Solution |
50mg/ml |
||
2. Anticancer medications |
||||
179 |
L - asparaginase |
Injection |
Lyophilized powder |
10.000 IU |
180 |
Bleomycin |
Injection |
Powder for Injection |
15mg |
181 |
Carboplatin |
Infusion |
Solution |
10mg/ml |
182 |
Cisplatin |
Injection |
Lyophilized powder |
10mg, 50mg |
183 |
Cyclophosphamide |
Oral administration |
Tablets/capsules |
25mg, 50mg |
Injection |
Powder for Injection |
200mg, 500mg |
||
184 |
Cytarabine |
Injection |
Lyophilized powder |
100mg, 500mg |
185 |
Dactinomycin |
Injection |
Powder for Injection |
0,5mg |
186 |
Doxorubicin hydrochloride |
Injection |
Powder for Injection |
10mg, 50mg |
187 |
Etoposide |
Oral administration |
Tablets/capsules |
50, 100mg |
Injection |
Powder for Injection |
50mg, 100mg |
||
Solution |
20mg/ml |
|||
188 |
Fluorouracil |
Injection |
Solution |
50mg/ml |
189 |
Hydroxycarbamide |
Oral administration |
Tablets/capsules |
250mg, 300mg, 400mg, 500mg, 1g |
190 |
Ifosfamide |
Injection |
Powder for Injection |
2g |
191 |
Mercaptopurine |
Oral administration |
Tablets/capsules |
50mg |
192 |
Methotrexate (sodium) |
Oral administration |
Tablets/capsules |
2,5mg |
Injection |
Powder for Injection |
10mg, 50mg |
||
193 |
Mitomycin |
Injection |
Powder for Injection |
2mg, 10mg |
194 |
Procarbazine |
Oral administration |
Tablets/capsules |
50mg |
195 |
Vinblastine sulfate |
Injection |
Powder for Injection |
10mg |
196 |
Vincristine Sulfate |
Injection |
Powder for Injection |
1mg, 5mg |
197 |
Allopurinol |
Oral administration |
Tablets/capsules |
100ng, 300mg |
198 |
Calcium folinate |
Oral administration |
Tablets/capsules |
15mg |
Injection |
Solution |
3mg/ml |
||
199 |
Chlorambucil |
Oral administration |
Tablets/capsules |
2mg |
200 |
Dacabazine |
Injection |
Powder for Injection |
100mg |
201 |
Daunorubicin |
Injection |
Powder for Injection |
50mg |
202 |
Mesna |
Oral administration |
Tablets/capsules |
400mg, 600mg |
Injection |
Solution |
100mg/ml |
||
203 |
Filgrastim |
Injection |
Solution |
30 million IU/ml |
3. Hormones and anti-hormones |
||||
204 |
Dexamethasone |
Oral administration |
Solution |
0,4mg/ml |
Dexamethasone phosphate (sodium) |
Injection |
Solution |
4mg/ml |
|
205 |
Hydrocortisone acetate |
Injection |
Suspension |
25mg/ml, 50mg/ml |
Hydrocortisone (sodium succinate) |
Injection |
Powder for Injection |
100mg |
|
206 |
Methylprednisolone (sodium succinate) |
Injection |
Powder for Injection |
40mg |
Methylprednisolone acetate |
Suspension |
40mg/ml |
||
207 |
Prednisolone |
Oral administration |
Tablets/capsules |
5mg, 25mg |
Syrup |
5mg/ml |
|||
208 |
Tamoxifen (citratee) |
Oral administration |
Tablets/capsules |
10mg, 20mg |
ix. ANTI-PARKINSON’S MEDICATIONS |
||||
209 |
Biperiden hydrochloride |
Oral administration |
Tablets/capsules |
2mg, 4mg |
Biperiden lactate |
Injection |
Solution |
5mg/ml |
|
210 |
Levodopa + Carbidopa |
Oral administration |
Tablets/capsules |
250mg + 25 mg. 100mg + 10mg |
X. Drugs affecting blood |
||||
1. Anti-anemic medications |
||||
211 |
Folic Acid (*) |
Oral administration |
Tablets/capsules |
1mg, 5mg |
212 |
Hydroxocobalamin |
Injection |
Solution |
1mg/ml |
213 |
Iron (Sulfate or oxalate) (*) |
Oral administration |
Tablets/capsules |
60mg |
214 |
Iron (sulfate + folic acid) (*) |
Oral administration |
Tablets/capsules |
60mg + 0,25mg |
2. Drugs affecting coagulation |
||||
215 |
Acenocoumarol |
Oral administration |
Tablets/capsules |
2mg, 4mg |
216 |
Aminocaproic Acid |
Injection |
Solution |
200mg/ml |
217 |
Tranexamic Acid |
Oral administration |
Tablets/capsules |
250mg, 500mg |
Injection |
Solution |
10% |
||
218 |
Carbazocrome dihydrate |
Oral administration |
Tablets/capsules |
10mg |
Carbazocrome sodium sulfonate |
Oral administration |
Tablets/capsules |
30mg |
|
Injection |
Solution |
5mg/ml |
||
219 |
Heparin sodium |
Injection |
Solution |
1.000, 5.000, 20.000, 25.000IU/ml |
220 |
Vitamin K1 |
Oral administration |
Tablets/capsules |
2mg, 5mg, 10 mg |
Injection |
Solution |
5mg/ml, 10mg/ml |
||
221 |
Protamine Sulfate |
Injection |
Solution |
10mg/ml |
222 |
Warfarin sodium |
Oral administration |
Tablets/capsules |
0,5 mg, 1 mg, 2mg, 5 mg |
xi. BLOOD PRODUCTS - polymer solutions |
||||
1. Polymer solutions |
||||
223 |
Dextran 40 |
Infusion |
Solution |
10% |
224 |
Dextran 60 |
Infusion |
Solution |
10% |
225 |
Dextran 70 |
Infusion |
Solution |
6% |
226 |
Gelatin |
Infusion |
Solution |
5%, 6% |
2. Blood products |
||||
227 |
Factor concentrates |
Infusion |
Lyophilization |
|
228 |
Prothrombin complex (coagulation factors II, VII, IX and X) concentrate (PCC) |
Infusion |
Lyophilization |
|
229 |
Albumin |
Infusion |
Solution |
5%, 20%, 25 % |
230 |
Fresh frozen plasma |
Infusion |
Solution for infusion |
|
xii. CARDIOVASCULAR DRUGS |
||||
1. Antianginal drugs |
||||
231 |
Atenolol |
Oral administration |
Tablets/capsules |
50mg, 100mg |
232 |
Diltiazem |
Oral administration |
Tablets/capsules |
30mg, 60mg |
233 |
Glyceryl trinitrate |
Oral administration |
Tablets/capsules |
2mg, 2,5mg, 3mg, 5mg |
Sublingual administration |
Tablets/capsules |
0,5mg |
||
Injection |
Solution |
0,5mg/ml, 1mg/ml, 5mg/ml |
||
234 |
Isosorbide dinitrate or Isosorbide mononitrate |
Oral administration |
Tablets/capsules |
5mg, 30mg, 60mg |
2. Antiarrhythmic drugs |
||||
235 |
Amiodarone hydrochloride |
Oral administration |
Tablets/capsules |
100mg, 200mg, 400mg |
Injection |
Solution |
50 mg/ml |
||
236 |
Atenolol |
Oral administration |
Tablets/capsules |
50mg, 100mg |
237 |
Lidocaine hydrochloride |
Injection |
Solution |
1%, 2% |
238 |
Propranolol hydrochloride |
Oral administration |
Tablets/capsules |
40mg |
Injection |
Solution |
0,5mg/ml, 1mg/ml |
||
239 |
Verapamil hydrochloride |
Oral administration |
Tablets/capsules |
40mg, 80mg |
Injection |
Solution |
2,5mg/ml |
||
240 |
Digoxin |
Oral administration |
Tablets/capsules |
62,5mcg, 250mcg |
Solution |
50mcg/ml |
|||
Injection |
Solution |
250mcg/ml |
||
241 |
Epinephrine (tartrate or hydrochloride) |
Injection |
Solution |
100mcg/ml |
3. Antihypertensive drugs |
||||
242 |
Amlodipine |
Oral administration |
Tablets/capsules |
2,5 mg, 5mg |
243 |
Captopril |
Oral administration |
Tablets/capsules |
25mg, 50mg |
244 |
Enalapril |
Oral administration |
Tablets/capsules |
5mg, 10mg, 20mg |
245 |
Furosemide |
Oral administration |
Tablets/capsules |
40mg |
Injection |
Solution |
10mg/ml |
||
246 |
Hydrochlorothiazide |
Oral administration |
Tablets/capsules |
25mg, 50mg |
247 |
Methyldopa |
Oral administration |
Tablets/capsules |
250mg |
248 |
Nifedipine |
Oral administration |
Tablets/capsules |
5mg, 10mg |
Extended-release tablets/capsules |
20mg |
|||
249 |
Propranolol hydrochloride |
Oral administration |
Tablets/capsules |
40mg |
250 |
Atenolol |
Oral administration |
Tablets/capsules |
50mg, 100mg |
251 |
Hydralazine |
Oral administration |
Tablets/capsules |
25mg, 50mg |
4. Antihypotensive drugs |
||||
252 |
Heptaminol (hydrochloride) |
Oral administration |
Tablets/capsules |
150mg |
Injection |
Solution |
62,5mg/ml |
||
5. Drugs for treatment of heart failure |
||||
253 |
Digoxin |
Oral administration |
Tablets/capsules |
62.5mcg, 250mcg |
Solution |
50mcg/ml |
|||
Injection |
Solution |
50mcg/ml, 250mcg/ml |
||
254 |
Dobutamine |
Injection |
Lyophilized powder |
250mg |
255 |
Dopamine hydrochloride |
Injection |
Solution |
40mg/ml |
256 |
Adrenalinee (tartrat or hydrochloride) |
Injection |
Solution |
1mg/ml |
257 |
Enalapril |
Oral administration |
Tablets/capsules |
2,5mg, 5mg, 10mg |
258 |
Furosemide |
Oral administration |
Tablets/capsules |
40mg |
Solution |
4mg/ml |
|||
Injection |
Solution |
10mg/ml |
||
259 |
Hydrochlorothiazide |
Oral administration |
Tablets/capsules |
25mg |
Solution |
10mg/ml |
|||
260 |
Spironolactone |
Oral administration |
Tablets |
25mg |
6. Antithrombotic drugs |
||||
261 |
Acetylsalicylic Acid (*) |
Oral administration |
Tablets |
100mg, 81mg |
Powder for solution |
100mg |
|||
262 |
Streptokinase |
Infusion |
Lyophilized powder |
1,5 million IU |
7. Hypolipidemic drugs |
||||
263 |
Atorvastatin |
Oral administration |
Tablets/capsules |
10mg, 20mg |
264 |
Fenofibrate |
Oral administration |
Tablets/capsules |
100mg, 300mg |
265 |
Simvastatin |
Oral administration |
Tablets/capsules |
5mg, 10mg, 20mg, 40mg |
xiii. External medications |
||||
1. Antifungal medications |
||||
266 |
Benzoic Acid + Salicylic Acid (*) |
Topical administration |
Cream, Ointment |
6%, 3% |
267 |
Alcohol septal ablation ASA (*) |
Topical administration |
Tincture |
|
268 |
Alcohol BSI (*) |
Topical administration |
Tincture |
|
269 |
Clotrimazole (*) |
Topical administration |
Cream |
1% |
270 |
Ketoconazole (*) |
Topical administration |
Cream |
2% |
271 |
Miconazole (*) |
Topical administration |
Cream |
2% |
272 |
Terbinafine (*) |
Topical administration |
Cream, Ointment |
1% |
273 |
Sodium thiosulfate (*) |
Topical administration |
Solution |
15% |
2. Anti-infective drugs |
||||
274 |
Neomycin + Bacitracin (*) |
Topical administration |
Cream |
5mg + 500 IU |
275 |
Povidone iodine (*) |
Topical administration |
Solution |
10% |
276 |
Potassium permanganate (*) |
Topical administration |
Solution |
0,5% |
277 |
Silver Sulfadiazine (*) |
Topical administration |
Cream |
1% |
3. Anti-itch and anti-inflammatory drugs |
||||
278 |
Betamethasone valerate (*) |
Topical administration |
Cream, Ointment |
0,1% |
279 |
Fluocinolone acetonide (*) |
Topical administration |
Ointment |
0,025% |
280 |
Hydrocortisone acetate (*) |
Topical administration |
Cream, Ointment |
1% |
281 |
Calamine (*) |
Topical administration |
Lotion |
|
4. Keratolytic drugs |
||||
282 |
Salicylic Acid (*) |
Topical administration |
Ointment |
3%, 5% |
283 |
Benzoyl peroxide (*) |
Topical administration |
Cream, lotion |
5%, 10% |
284 |
Fluorouracil |
Topical administration |
Ointment |
5% |
285 |
Urea (*) |
Topical administration |
Ointment, cream |
10% |
6. Medications for treatment of scabies |
||||
286 |
Benzyl benzoate (*) |
Topical administration |
Cream |
25% |
287 |
Diethyl phthalate (*) |
Topical administration |
Solution |
10% |
Ointment, cream |
5,2/8g, 19,5/30g (65% kl/kl) |
|||
288 |
Permethrin (*) |
Topical administration |
Ointment |
5% |
Lotion |
1% |
|||
xiv. Medications used for DIAGNOSis |
||||
1. Ophthalmic medications |
||||
289 |
Fluorescein (sodium) |
Eye drops |
Solution |
2% |
Injection |
Solution |
100mg/ml |
||
290 |
Pilocarpine |
Eye drops |
Solution |
1mg/ml, 5mg/ml |
291 |
Tropicamide |
Eye drops |
Solution |
0,5% |
2. Contrast agents |
||||
292 |
Amidotrizoate (Sodium or meglumine) |
Injection |
Solution |
140mg - 420mg of iodine/ml |
293 |
Barium Sulfate |
Oral administration |
Powder for suspension |
140g, 200g |
294 |
lohexol |
Injection |
Solution |
140mg - 350mg of iodine/ml |
295 |
Iopromide |
Injection |
Solution |
300mg of iodine/ml |
296 |
Meglumine iotroxate |
Injection |
Solution |
5g - 8g of iodine in 100ml - 250ml |
xv. Antiseptics and disinfectants |
||||
297 |
Chlorhexidine digluconate (*) |
Topical administration |
Solution |
5% |
298 |
70% alcohol (*) |
Topical administration |
|
|
299 |
Iodine alcohol (*) |
Topical administration |
Solution |
2,5% |
300 |
Hydrogen peroxide (*) |
Topical administration |
Solution |
3% |
301 |
Povidon iodine (*) |
Topical administration |
Solution |
10% |
xvi. DIURETICS |
||||
302 |
Furosemide |
Oral administration |
Tablets/capsules |
20mg, 40mg |
Injection |
Solution |
10mg/ml |
||
303 |
Hydrochlorothiazide |
Oral administration |
Tablets/capsules |
6,25mg, 25mg, 50mg |
304 |
Mannitol |
Infusion |
Solution |
10%; 20% |
305 |
Spironolactone |
Oral administration |
Tablets/capsules |
25mg, 50mg, 75mg |
xvii. GASTROINTESTINAL DRUGS |
||||
1. Drugs against stomach and duodenal ulcers |
||||
306 |
Cimetidine |
Oral administration (*) |
Tablets/capsules |
200 mg, 400mg |
Injection |
Solution |
100mg/ml |
||
307 |
Bismuth (carbonate, tripotassium dicitratee…) (*) |
Oral administration |
Tablets/capsules |
120mg |
308 |
Famotidine |
Oral administration (*) |
Tablets/capsules |
20mg, 40mg |
Injection |
Solution |
4mg/ml |
||
309 |
Magnesium hydroxide + aluminum hydroxide (*) |
Oral administration |
Suspension |
55mg Magnesium oxide + 64mg aluminum oxide/ml |
Tablets, Chewable tablets |
200mg + 200mg, 400mg + 400mg, 500mg + 500mg |
|||
310 |
Omeprazole |
Oral administration |
Tablets/capsules |
20mg |
311 |
Pantoprazole |
Oral administration |
Tablets/capsules |
40mg |
Injection |
Powder for Injection |
40mg |
||
312 |
Ranitidine (*) |
Oral administration |
Tablets/capsules |
150mg, 300mg |
2. Antiemetics |
||||
313 |
Metoclopramide hydrochloride |
Oral administration |
Tablets/capsules |
10mg |
Injection |
Solution |
5mg/ml |
||
314 |
Promethazine hydrochloride (*) |
Oral administration |
Tablets/capsules |
10mg, 50mg |
315 |
Dexamethasone |
Oral administration |
Tablets/capsules |
0,5mg, 0,75mg, 1,5mg, 4mg |
Dexamethasone |
Solution |
0,1mg/ml, 0,4mg/ml |
||
Dexamethasone sodium phosphate |
Injection |
Solution |
4mg/ml |
|
316 |
Ondansetron (hydrochloride) |
Oral administration |
Tablets/capsules |
4mg, 8mg, 24mg |
Solution |
0,8mg/ml |
|||
Injection |
Solution |
2mg/ml |
||
3. Antispasmodic drugs |
||||
317 |
Alverine (citratee) |
Oral administration |
Tablets/capsules |
10mg, 60mg |
Injection |
Solution |
15mg/ml |
||
318 |
Atropine Sulfate |
Oral administration |
Tablets/capsules |
0,25mg |
Injection |
Solution |
0,25mg/ml |
||
319 |
Hyoscine butylbromide |
Oral administration (*) |
Tablets/capsules |
10mg |
Injection |
Solution |
20mg/ml |
||
320 |
Papaverine hydrochloride |
Oral administration |
Tablets/capsules |
40mg |
Injection |
Solution |
40mg/ml |
||
4. Laxatives |
||||
321 |
Bisacodyl (*) |
Oral administration |
Tablets/capsules |
5mg, 10mg |
322 |
Magnesium sulfate (*) |
Oral administration |
Powder |
5g |
5. Medicines used in diarrhoea |
||||
a. Drugs for prevention of body water loss |
||||
323 |
Oresol (*) |
Oral administration |
Powder for solution |
|
b. Anti-diarrheal drugs |
||||
324 |
Atapulgite (*) |
Oral administration |
Powder |
3g |
325 |
Berberine chloride (*) |
Oral administration |
Tablets/capsules |
10mg |
326 |
Loperamide (*) |
Oral administration |
Tablets/capsules |
2mg |
327 |
Zinc Sulfate (*) |
Oral administration |
Tablets/capsules |
20mg |
6. Drugs for treatment of hemorrhoids |
||||
328 |
Diosmin (*) |
Oral administration |
Tablets/capsules |
150mg, 300mg |
7. Other drugs |
||||
329 |
Pancreatic enzymes (*) |
Ingredients: lipase, protease and amylase Age-appropriate dosage forms and doses |
||
xviii. Hormones, contraceptives |
||||
1. Adrenal hormones and synthetic substitutes |
||||
330 |
Dexamethasone |
Oral administration |
Tablets/capsules |
0,5mg, 1mg |
Dexamethasone phosphate (sodium) |
Injection |
Solution |
4mg/ml |
|
331 |
Hydrocortisone |
Oral administration |
Tablets/capsules |
5mg, 10mg, 20mg |
Hydrocortisone acetate |
Injection |
Suspension |
25mg/ml, 50mg/ml |
|
Hydrocortisone (sodium succinate) |
Injection |
Powder for Injection |
100mg |
|
332 |
Prednisolone |
Oral administration |
Tablets/capsules |
1mg, 5mg |
333 |
Fludrocortisone |
Oral administration |
Tablets/capsules |
100microgram |
2. Androgens |
||||
334 |
Methyltestosterone |
Sublingual administration |
Tablets/capsules |
5mg, 10mg |
Oral administration |
Tablets/capsules |
0,025mg, 0,1 mg |
||
335 |
Testosterone undecanoate |
Oral administration |
Tablets/capsules |
40mg |
Testosterone enanthate or Testosterone undecanoate |
Injection |
Oil solution |
200mg/ml, 250mg/ml |
|
3. Contraceptives |
||||
336 |
Ethinylestradiol + Levonorgestrel (*) |
Oral administration |
Tablets/capsules |
30mcg + 150mcg |
337 |
Ethinylestradiol + Norethisterone (*) |
Oral administration |
Tablets/capsules |
50mcg + 100mcg, 35mcg + 1 mg |
338 |
Levonorgestrel |
Oral administration |
Tablets/capsules |
750 mcg, 30 mcg, 1,5mg |
339 |
Norethisterone enanthate |
Injection |
Oil solution |
200mg/ml |
340 |
Estradiol cypionate + medroxyprogesterone acetate |
Injection |
Suspension |
5mg + 25mg/0,5ml |
341 |
Medroxyprogesterone acetate |
Injection |
Suspension |
150mg/ml |
4. Estrogens |
||||
342 |
Ethinyl estradiol (*) |
Oral administration |
Tablets/capsules |
10mcg, 50mcg |
5. Implantable contraceptives |
||||
343 |
Levonorgestrel-releasing implant |
Implantation |
Two levonorgestrel-releasing implants |
75mg/implant |
5. Insulin and hypoglycemic drugs |
||||
344 |
Acarbose |
Oral administration |
Tablets/capsules |
50mg, 100mg |
345 |
Glibenclamide |
Oral administration |
Tablets/capsules |
2,5mg, 5mg |
346 |
Gliclazide |
Oral administration |
Tablets/capsules |
30mg, 80mg |
347 |
Insulin |
Injection |
Solution |
40 lU/ml, 100 lU/ml |
348 |
Intermediate-Acting Insulin |
Injection |
Insulin zinc suspension or Isophane Insulin Suspension |
100 IU/ml, 40 IU/ml |
349 |
Metformin |
Oral administration |
Tablets/capsules |
500mg, 850mg |
6. Ovulation-induction drugs |
||||
350 |
Clomifen citratee |
Oral administration |
Tablets/capsules |
50mg |
351 |
Gonadotropins |
Oral administration |
Lyophilized powder |
500IU, 1.500 IU |
7. Progesterons |
||||
352 |
Norethisterone |
Oral administration |
Tablets/capsules |
5mg |
353 |
Progesterone |
Injection |
Oil solution |
10mg/ml, 25mg/ml, 50mg/ml |
354 |
Medroxyprogesterone acetate |
Oral administration |
Tablets/capsules |
5mg |
8. Thyroid hormones and antithyroid medicines |
||||
355 |
Carbimazole |
Oral administration |
Tablets/capsules |
5mg |
356 |
Levothyroxine sodium |
Oral administration |
Tablets/capsules |
50mcg, 100mcg |
357 |
Methylthiouracil |
Oral administration |
Tablets/capsules |
50mg |
358 |
Propylthiouracil |
Oral administration |
Tablets/capsules |
50mg |
359 |
Potassium iodide |
Oral administration |
Tablets/capsules |
60mg |
360 |
Lugol’s solution |
Oral administration |
Solution |
130mg/ml |
9. Diabetes insipidus medications |
||||
361 |
Vasopressin |
Injection |
Solution |
20IU/ml (4mcg/ml) |
362 |
Desmopressin acetate |
Oral administration |
Tablets/capsules |
0,1mg, 0,2mg |
Injection |
Solution |
4mcg/ml |
||
xix. IMMUNITY BIOLOGICAL PRODUCTS |
||||
1. Sera and Immunoglobulins |
||||
363 |
Human normal Immunoglobulin |
Injection |
Solution |
|
364 |
Antirabies serum |
Injection |
Solution |
1.000IU, 2.000IU/ml |
365 |
Anti-tetanus serum |
Injection |
Solution |
1.500IU, 10.000lU/ml |
366 |
Anti-venom serum |
Injection |
Solution |
|
2. Vaccines |
||||
367 |
Tuberculosis vaccine |
Injection |
|
|
368 |
DPT vaccine |
Injection |
|
|
369 |
DTwP-HepB-Hib vaccine (5-in-1 combination vaccine) |
Injection |
|
|
370 |
Measles vaccine |
Injection |
|
|
371 |
Hepatitis B vaccine |
Injection |
|
|
372 |
Polio vaccine |
Oral administration |
|
|
373 |
Tetanus vaccine |
Injection |
|
|
374 |
Japanese encephalitis vaccine |
Injection |
|
|
375 |
Typhoid vaccine |
Injection |
|
|
376 |
Cholera vaccine |
Oral administration |
|
|
377 |
Rubella vaccine |
Injection |
|
|
378 |
Combined vaccine against Diphtheria and Tetanus |
Injection |
|
|
379 |
Rabies vaccine |
Injection |
|
|
380 |
DTaP/IPV/Hib/HepB vaccine (6-in-1 vaccine) |
Injection |
|
|
381 |
Pneumonia and Streptococcus pneumoniae vaccine |
Injection |
|
|
382 |
Pneumococcal polysaccarides and nontypeable Haemophilus influenzae (Nthi) protein D conjugate vaccine (Phid-Cv) |
Injection |
|
|
383 |
Combined vaccine against diphtheria, tetanus, whooping cough and polio |
Injection |
|
|
384 |
Four-in-one vaccine against diphtheria, tetanus, whooping cough and Hib |
Injection |
|
|
385 |
Combined vaccine against measles and rubella |
Injection |
|
|
386 |
Vaccines for preventing rotavirus diarrhoea |
Oral administration |
|
|
387 |
Seasonal influenza vaccine |
Injection |
|
|
388 |
Meningococcal vaccine |
Injection |
|
|
389 |
Vaccine against bacterial meningitis |
Injection |
|
|
390 |
Vaccine against cervical cancer |
Injection |
|
|
391 |
Combined vaccine against Measles - Mumps - Rubella |
Injection |
|
|
392 |
Varicella vaccine |
Injection |
|
|
393 |
Hepatitis A vaccine |
Injection |
|
|
394 |
Hib vaccine |
Injection |
|
|
XX. MUSCLE RELAXANTS AND REVERSAL AGENTS |
||||
395 |
Neostigmine bromide |
Oral administration |
Tablets/capsules |
15mg |
Neostigmine methylsulfate |
Injection |
Solution |
0,5mg/ml, 2,5mg/ml |
|
396 |
Pancuronium bromide |
Injection |
Solution |
2mg/ml |
397 |
Suxamethonium chloride |
Injection |
Solution |
50mg/ml |
398 |
Alcuronium chloride |
Injection |
Solution |
5mg/ml |
399 |
Pyridostigmine bromide |
Oral administration |
Tablets/capsules |
60mg |
Injection |
Solution |
1mg/ml |
||
400 |
Veruconium bromide |
Injection |
Powder for Injection |
10mg |
XXI. Medications for treatment of eyes, ears , nose and throat conditions |
||||
1. Anti-infective drugs, antiviral drugs |
||||
401 |
Aciclovir |
ophthalmic administration |
Ointment |
3% |
402 |
Argyrol (*) |
Eye drops |
Solution |
3% |
403 |
Chloramphenicol |
Eye drops |
Solution |
0,4% |
404 |
Gentamicin (sulfate) |
Eye drops |
Solution |
0,3% |
405 |
Neomycin (sulfate) |
Eye drops, ear drops |
Solution |
0,5% |
406 |
Ofloxacin |
Eye drops, ear drops |
Solution |
0,3% |
407 |
Sulfacetamide sodium |
Eye drops |
Solution |
10% |
408 |
Tetracycline hydrochloride |
Ophthalmic administration |
Ointment |
1% |
409 |
Ciprofloxacin (hydrochloride) |
Eye drops |
Solution |
0,3% |
Ophthalmic administration |
Ointment |
0,3% |
||
2. Anti-inflammatory drugs |
||||
410 |
Hydrocortisone |
Ophthalmic administration |
Ointment |
1% |
411 |
Prednisolone sodium phosphate |
Eye drops |
Solution |
0,5% |
3. Local anesthetics |
||||
412 |
Tetracaine hydrochloride |
Eye drops |
Solution |
0,5% |
4. Drugs causing pupil constriction and reducing intraocular pressure (IOP) |
||||
413 |
Acetazolamide |
Oral administration |
Tablets/capsules |
250mg |
414 |
Pilocarpine (hydrochloride or nitrate) |
Eye drops |
Solution |
2%, 4% |
415 |
Timolol |
Eye drops |
Solution |
3,25%, 0,5% |
5. Drugs causing dilated pupils |
||||
416 |
Atropine sulfate |
Eye drops |
Solution |
0,1%, 0,5%, 1,0% |
6. Otorhinolaryngological drugs |
||||
417 |
Hydogen peroxide (*) |
Topical administration |
Solution |
3% |
418 |
Naphazolin (*) |
Nasal drops |
Solution |
0,05% |
419 |
Sunfarine (Ingredients: Sodium sulfacetide + ephedrine hydrochloride) |
Nasal drops |
Solution |
0,01g + 0,01g/ml |
420 |
Xylometazolin (*) |
Nasal drops |
Solution |
0,05%, 0,1% |
421 |
Acetic acid |
Topical administration |
Alcohol |
2% |
422 |
Budesonide (*) |
Nasal spray |
Solution |
100mcg/spray |
XXII. DRUGS used for labor induction, treatment of postpartum hemorrhage and prevention of preterm birth |
||||
1. Drugs for labor induction and postpartum hemorrhage |
||||
a. Drugs for labor induction |
||||
423 |
Oxytocin |
Injection |
Solution |
5IU, 10IU/ml |
b. Drugs for postpartum hemorrhage |
||||
424 |
Ergometrine maleate |
Injection |
Solution |
0,2mg/ml |
425 |
Oxytocin |
Injection |
Solution |
5IU, 10IU/ml |
426 |
Misoprostol |
Oral administration |
Tablets/capsules |
200mg |
427 |
Mifepristone + Misoprostol |
Oral administration |
Tablets/capsules |
200mg + 200mg |
2. Drugs for prevention of preterm birth |
||||
428 |
Papaverine |
Oral administration |
Tablets/capsules |
40mg |
429 |
Salbutamol (Sulfate) |
Oral administration |
Tablets/capsules |
2mg, 4mg |
Injection |
Solution |
0,5mg/ml, 1mg/ml |
||
430 |
Nifedipine |
Oral administration |
Tablets/capsules |
10mg |
xxiii. Solution used for peritoneal dialysis |
||||
431 |
Solution used for peritoneal dialysis |
Peritoneal dialysis |
Solution |
|
432 |
Acetate-based kidney dialysis fluid |
Kidney dialysis |
Solution |
|
xxiv. Medicines for mental and behavioural disorders |
||||
1. Antipsychotics |
||||
433 |
Clorpromazine hydrochloride |
Oral administration |
Syrup |
5mg/ml |
Tablets/capsules |
25 mg, 100mg |
|||
Injection |
Solution |
12,5mg/ml, 25mg/ml |
||
434 |
Diazepam |
Oral administration |
Tablets/capsules |
2mg, 5mg |
Injection |
Solution |
5mg/ml |
||
435 |
Haloperidol |
Oral administration |
Tablets/capsules |
1mg, 2mg, 5mg |
Injection |
Solution |
5mg/ml |
||
436 |
Levomepromazine |
Oral administration |
Tablets/capsules |
25mg |
Injection |
Solution |
25mg/ml |
||
437 |
Risperidon |
Oral administration |
Tablets/capsules |
1mg, 2mg |
438 |
Sulpiride |
Oral administration |
Tablets/capsules |
50mg |
Injection |
Solution |
50mg/ml |
||
439 |
Fluphenazine |
Injection |
Solution |
2mg/ml |
2. Antidepressants |
||||
440 |
Amitriptyline hydrochloride |
Oral administration |
Tablets/capsules |
25mg |
441 |
Fluoxetine |
Oral administration |
Tablets/capsules |
20mg |
3. Mood stabilizers |
||||
442 |
Valproic Acid |
Oral administration |
Tablets/capsules |
200mg, 500mg |
443 |
Carbamazepine |
Oral administration |
Tablets/capsules |
100mg, 200mg |
444 |
Lithium carbonate |
Oral administration |
Tablets/capsules |
300mg |
4. Medicines for treatment of phobias and panic disorders |
||||
445 |
Clomipramine |
Oral administration |
Tablets/capsules |
10mg, 25mg |
5. Medicines for treatment of opioid use disorder |
||||
446 |
Methadone |
Oral administration |
Solution |
5mg/ml. 10mg/ml, 1mg/ml, 2mg/ml |
xxv. MEDICines acting on THE RESPIRATORY TRACT |
||||
1. Drugs for treatment of asthma and chronic obstructive pulmonary disease |
||||
447 |
Beclometasone dipropionate (*) |
Respiratory route |
Inhalations (nebulization) |
50mcg,100mcg/spray |
448 |
Salbutamol (sulfate) |
Oral administration |
Tablets/capsules |
2mg, 4mg |
Solution |
0,4mg/ml |
|||
Respiratory route |
Inhalations (nebulization) |
100mcg/spray |
||
Injection |
Solution |
50 mcg/ml |
||
449 |
Terbutaline |
Injection |
Solution |
0,5mg/ml |
450 |
Budesonide (*) |
Respiratory route |
Inhalations (nebulization) |
100mcg/spray 200mcg/spray |
451 |
Adrenaline (tartrate or hydrochloride) |
Injection |
Solution |
1mg/ml |
452 |
Ipratropium bromide |
Respiratory route |
Inhalations (nebulization) |
20 mcg/spray |
2. Drugs for treatment of secretion disorders |
||||
453 |
Acetylcysteine |
Oral administration (*) |
Tablets/capsules |
100mg, 200mg |
Powder for suspension |
200mg |
|||
Injection |
Solution |
200mg/ml |
||
454 |
Alimemazine (*) |
Oral administration |
Syrup |
0,5mg/ml |
455 |
Bromhexine hydrochloride (*) |
Oral administration |
Tablets/capsules |
4mg, 8mg |
3. Other drugs |
||||
456 |
Dextromethorphan (*) |
Oral administration |
Tablets/capsules |
15mg |
xxvi. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES |
||||
1. Oral medications |
||||
457 |
Oresol (*) |
Oral administration |
Powder for solution |
|
458 |
Potassium chloride |
Oral administration |
Tablets/capsules |
600mg |
2. Drugs for infusion |
||||
459 |
Amino acid solution |
Infusion |
Solution |
5%, 10% |
460 |
Glucose solution |
Injection |
Solution |
5%, 10%, 50% |
Infusion |
Solution |
5%, 30% |
||
461 |
Ringer lactate solution |
Infusion |
Solution |
|
462 |
Calcium chloride solution |
Intravenous injection |
Solution |
10% |
463 |
Potassium chloride |
Infusion |
Solution |
11,2% |
464 |
Sodium chloride |
Injection, infusion |
Solution |
0,9%, 10% |
465 |
Sodium hydrocarbonate |
Infusion |
Solution |
1,4%, 8,4% |
3. Other drugs |
||||
466 |
Distilled water for injection |
Dilution |
Solvent |
|
xxvii. VITAMINs and Minerals |
||||
467 |
Calcium gluconate |
Oral administration (*) |
Tablets/capsules |
500mg, 1g |
Injection |
Solution |
100mg/ml |
||
468 |
Vitamin A (*) |
Oral administration |
Tablets/capsules |
5.000 IU |
469 |
Vitamin A + D (*) |
Oral administration |
Tablets/capsules |
5.000 IU + 500 IU |
470 |
Thiamine hydrochloride or Thiamine nitrate (*) |
Oral administration |
Tablets/capsules |
10mg, 50mg, 100mg |
Thiamine hydrochloride |
Injection |
Solution |
25mg/ml, 50mg/ml |
|
471 |
Vitamin B2 (*) |
Oral administration |
Tablets/capsules |
5mg |
472 |
Vitamin B6 (*) |
Oral administration |
Tablets/capsules |
25mg, 100mg |
473 |
Vitamin C (*) |
Oral administration |
Tablets/capsules |
50mg, 100mg, 500mg |
474 |
Vitamin PP (*) |
Oral administration |
Tablets/capsules |
50mg |
xxviii. Medications used for premature babies |
||||
475 |
Caffeine citratee |
Oral administration |
Solution |
20mg/ml |
Injection |
Solution |
20mg/ml |
||
476 |
Ibuprofen |
Injection |
Solution |
5mg/ml |
477 |
Surfactant (Phospholipid extracted from swine or cow lung with surfactant properties) |
Intratracheal instillation |
Suspension |
25mg/ml, 80mg/ml |
xxix. DRUGS FOR TREATMENT OF GOUT AND RHEUMATISM |
||||
1. Drugs for treatment of gout |
||||
478 |
Allopurinol |
Oral administration |
Tablets/capsules |
100mg, 300mg |
479 |
Colchicine |
Oral administration |
Tablets/capsules |
1mg |
2. Drugs used in rheumatoid arthritis |
||||
480 |
Chloroquine (phosphate or sulfate) |
Oral administration |
Tablets |
100mg, 150mg |
481 |
Methotrexate (sodium) |
Oral administration |
Tablets/capsules |
2,5mg |
xxx. Other drugs |
||||
482 |
Bach linh, Cat canh, Ty ba diep/Ty ba, Tang bach bi, Ma hoang, Thien mon dong/Mach mon, bac ha/la bac ha, Ban ha che/Ban ha, Bach bo, Mo muoi/O mai, Cam thao, Menthol, (Bach phan), (Bang sa), (Ngu vi tu). |
Oral administration |
|
|
483 |
Bo mam, Eucalyptol, Nuc nac, Vien chi, Tran bi, An tuc huong, Hung chanh, Sodium benzoate. |
Oral administration |
|
|
484 |
Bo mam, Eucalyptol, Nuc nac, Vien chi, Tran bi, An tuc huong, Hung chanh, Sodium benzoate. |
Oral administration |
|
|
485 |
Camphor, Cinnamon oil, (Methyl salicylate), (Menthol/Eucalyptol/Cineol). |
Topical administration |
|
|
486 |
Camphor, Tinh dau bac ha, Tinh dau tram, Tinh dau huong nhu trang/Tinh dau dinh huong, Tinh dau que, (Menthol) |
Topical administration |
|
|
487 |
Total unsaponifiable extract from avocado, total unsaponifiable extract from soybean oil. |
Oral administration |
|
|
488 |
Cineol, essential oil of Zingiber officinale, coleus leaf, Menthol, (Eucalyptol). |
Oral administration |
|
|
489 |
Dan sam, Tam that, Borneol/Camphor. |
Oral administration |
|
|
490 |
Eucalyptol, essential oil of Zingiber officinale, essential oil of Pericarpium Citri Reticulatae, essential oil of mentha pepperita, essential oil of Coleus amboinicus |
Oral administration |
|
|
491 |
Coleus amboinicus, Oroxylum indicum, Cineol. |
Oral administration |
|
|
492 |
La vong/vong nem, (Lac tien), (la sen), (tam sen), (Rotundin), (Trinh nu) |
Oral administration |
|
|
493 |
Lien Kieu, Kim ngan hoa, Hoang cam, Menthol, Eucalyptol, Camphor. |
Nasal spray, solution |
|
|
494 |
Mach mon, Bach bo, Cam thao, Bo mam, Cat canh, Tran bi, Menthol |
Oral administration |
|
|
495 |
Menthol, Camphor, Eucalyptol, Methyl salicylate, essential oil of cinnamon. |
Topical administration |
|
|
496 |
Menthol, Tinh dau tram, Methyl salicylate, Tinh dau long nao, essential oils of melaleuca, camphor, whilte basil, cinnamon, ginger. |
Topical administration |
|
|
497 |
Methy salicylate, Camphor, Menthol, essential oil of cinnamon, dried cobra venom |
Topical administration |
|
|
498 |
Moc hoa trang, Moc huong, Berberine chloride |
Oral administration |
|
|
499 |
Moc huong, Berberine chloride, (Xich thuoc/Bach thuoc), (Ngo thu du). |
Oral administration |
|
|
500 |
Nghe vang, Menthol, Camphor. |
Nasal sprays, solution |
|
|
501 |
Nguu hoang/Nguu hoang nhan tao, Thach cao, Dai hoang, Hoang cam, Cat canh, licorice, Borneol |
Oral administration |
|
|
502 |
Nguu tat, nghe, Rutin. |
Oral administration |
|
|
503 |
Nha dam tu, Berberine, garlic, Cat can, Moc huong. |
Oral administration |
|
|
504 |
Dried cobra venom, Menthol, Methyl salicylate, Camphor |
Topical administration |
|
|
505 |
O dau, Ma tien/Dia lien, Thien nien kien, Que nhuc/Que chi, Dai hoi, Huyet giac, Tinh dau Long nao, Methyl salicylate. |
Topical administration |
|
|
506 |
Essential oil of pine, Thien nien kien, Menthol, Methyl salicylate. |
Topical administration |
|
|
507 |
Tran bi, Cat canh, Tien ho, To diep, Tu uyen, Thien mon, Tang bach bi, Tang diep, licorice, O mai, Khuong hoang, Menthol. |
Oral administration |
|
|
508 |
Ty ba diep/Ty ba la, Cat canh, Bach bo, Tien ho, Tang bach bi, Thien mon/Thien mon dong, Bach linh/Phuc linh, licorice, Hoang cam, Cineol, (Menthol). |
Oral administration |
|
|
509 |
Xuyen boi mau, Ty ba diep, Sa sam, Phuc linh, Tran bi, Cat canh, Ban ha, Ngu vi tu, Qua lau nhan, Vien chi, Kho hanh nhan, ginger, O mai, licorice, honey, Menthol, Benzoic Acid. |
Oral administration |
|
|
510 |
Xuyen khung, Tan giao, Bach chi, Duong quy, Mach mon, Hong sam, Ngo thu du, Ngu vi tu, Borneol. |
Oral administration |
|
|
Notes:
- The combined salts and acids placed in brackets next to the name of the main active ingredient recorded in column (2) are salts and acids combined with the main active ingredients used in preparation whose concentrations and contents are not in column (5). Concentrations and contents specified in column (5) are calculated as those of the main active ingredients outside the brackets. Example:
+ No. 25 – Dexamethasone phosphate (sodium): the amount of 4mg/ml written in column (5) is the content of Dexamethasone phosphate, but the salt used for preparation is Dexamethasone sodium phosphate.
+ No. 86 - Cefotaxim (sodium): the amounts of 250mg, 500mg, 1g written in column (5) are the contents of cefotaxime, but the salt used for preparation is cefotaxime sodium.
- The concentrations and contents of the combined salts and acids next to the names of the main active ingredients recorded in column (2) which are not placed in brackets are included in those written in column (5). Example:
+ No. 10 - Ephedrine hydrochloride: 30mg/ml in column (5) is the concentration of Ephedrine hydrochloride.
+ No. 407 – Sulfacetamide sodium: 10% in column (5) is the concentration of Sulfacetamide sodium.
- Regarding other groups of medications: specify full names of all medicinal ingredients of each medication; a slash “/” indicates ingredients that are interchangeable; the ingredients in parentheses “()” can be increased or decreased.
------------------------------------------------------------------------------------------------------
This translation is made by THƯ VIỆN PHÁP LUẬT, Ho Chi Minh City, Vietnam and
for reference purposes only. Its copyright is owned by THƯ VIỆN PHÁP LUẬT
and protected under Clause 2, Article 14 of the Law on Intellectual Property.Your comments are always welcomed